Albert Hagège

Active 1989–2025

Also published as
Albert Hagege
96
Papers
22,334
Citations
71
h-index
91
i10-index

Citations

Citations per year for Albert Hagège1967: 1 citations1982: 1 citations1986: 1 citations1991: 2 citations1992: 3 citations1993: 7 citations1994: 14 citations1995: 15 citations1996: 7 citations1997: 14 citations1998: 39 citations1999: 31 citations2000: 15 citations2001: 39 citations2002: 49 citations2003: 116 citations2004: 98 citations2005: 120 citations2006: 117 citations2007: 107 citations2008: 84 citations2009: 87 citations2010: 82 citations2011: 99 citations2012: 83 citations2013: 57 citations2014: 94 citations2015: 142 citations2016: 166 citations2017: 179 citations2018: 217 citations2019: 577 citations2020: 656 citations2021: 733 citations2022: 497 citations2023: 410 citations2024: 702 citations2025: 332 citations2026: 9 citations1968–1981: no citations, so these years are not shown1983–1985: no citations, so these years are not shown1987–1990: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,910 citing papers, 20.9% of this breakdownUnited Kingdom: 806 citing papers, 8.8% of this breakdownItaly: 709 citing papers, 7.8% of this breakdownFrance: 558 citing papers, 6.1% of this breakdownGermany: 519 citing papers, 5.7% of this breakdownChina: 480 citing papers, 5.2% of this breakdownNetherlands: 371 citing papers, 4.1% of this breakdownCanada: 317 citing papers, 3.5% of this breakdownSpain: 310 citing papers, 3.4% of this breakdownJapan: 282 citing papers, 3.1% of this breakdownAustralia: 234 citing papers, 2.6% of this breakdownSwitzerland: 172 citing papers, 1.9% of this breakdown
0%20.9%Other 26.9%

Fields

  • Medicine75%
  • Biochemistry, Genetics and Molecular Biology19.5%
  • Engineering2%
  • Neuroscience1.5%
  • Materials Science1.1%
  • Computer Science0.2%
  • Other0.7%

Topics

  • Cardiomyopathy and Myosin Studies10.8%
  • Cardiovascular Function and Risk Factors7.4%
  • Tissue Engineering and Regenerative Medicine5.6%
  • Cardiovascular Effects of Exercise4.5%
  • Congenital heart defects research3.3%
  • Mesenchymal stem cell research3%
  • Other65.4%

Coauthors

All papers

Open in search
  1. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Emeline M. Van Craenenbroeck, Miloš Kubánek, David Zemánek, Morten K. Jensen, Jens Mogensen, Jens Jakob Thune, Philippe Charron, Albert Hagège, Olivier Lairez, Jean‐Noël Trochu, Christoph Axthelm, H DUENGEN, Norbert Frey, Veselin Mitrović, Michael R. Preusch, Jeanette Schulz‐Menger, Tim Seidler, Michael Arad, Majdi Halabi, Amos Katz, Daniel Monakier, Offir Paz, Samuel Viskin, Donna R. Zwas, Iacopo Olivotto, Hans‐Peter Brunner‐La Rocca, Michelle Michels, Dariusz Dudek, Zofia Oko‐Sarnowska, Artur Oręziak, Wojciech Wojakowski, Nuno Cardim, Helder Pereira, Roberto Barriales‐Villa, Pablo García Pavía, Juan Gimeno Blanes, Rafael Hidalgo Urbano, Luis Miguel Rincón Diaz, Perry Elliott, Zaheer Yousef, Theodore P. Abraham, Kia Afshar, Paulino Álvarez, Richard G. Bach, Richard C. Becker, Lubna Choudhury, David Fermin, Daniel Jacoby, John L. Jefferies, Christopher M. Kramer, Neal K. Lakdawala, Steven J. Lester, Ali J. Marian, Ahmad Masri, Matthew J. Maurer, Sherif F. Nagueh, Anjali Owens, David S. Owens, Florian Rader, Sara Saberi, Mark V. Sherrid, Jamshid Shirani, John D. Symanski, Aslan T. Turer, Andrew Wang, Omar Wever‐Pinzon, Matthew T. Wheeler, Timothy C. Wong, Mohamad H. Yamani - The Lancet 2020 cited by 1,210

  2. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy

    Authors: , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2014 cited by 4,317

  3. Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lisa Meng, Amy Wohltman, Theodore P. Abraham - New England Journal of Medicine 2024 cited by 282

  4. Cardiac Involvement in Fabry Disease

    Authors: , , , , , , , , , , , , , - Journal of the American College of Cardiology 2021 cited by 309

  5. Transplantation of Human Embryonic Stem Cell–Derived Cardiovascular Progenitors for Severe Ischemic Left Ventricular Dysfunction

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2018 cited by 442

  6. An Expert Consensus Document on the Management of Cardiovascular Manifestations of Fabry Disease

    Authors: , , , , , , , , , , , , - European Journal of Heart Failure 2020 cited by 219

  7. Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nicolas Sadoul, Xavier Waintraub, Khadija Chikhaoui, Philippe Mabo, Nicolas Combes, Philippe Maury, Jean‐Marc Sellal, Usha B. Tedrow, Jonathan M. Kalman, Jitendra K. Vohra, Alexander F.A. Androulakis, Katja Zeppenfeld, Tina Thompson, Christine Barnérias, Henri-Marc Bécane, Éric Bieth, Franck Boccara, Damien Bonnet, Françoise Bouhour, Stéphane Boulé, Anne‐Claire Bréhin, Françoise Chapon, Pascal Cintas, Jean‐Marie Cuisset, Jean‐Marc Davy, Annachiara De Sandre‐Giovannoli, Florence Démurger, Isabelle Desguerre, Klaus Dieterich, Julien Durigneux, Andoni Echaniz‐Laguna, Romain Eschalier, Ana Ferreiro, Xavier Ferrer, Christine Francannet, Mélanie Fradin, Bénédicte Gaborit, Arnaud Gay, Albert Hagège, Arnaud Isapof, Isabelle Jéru, Raúl Juntas Morales, Emmanuelle Lagrue, Nicolas Lamblin, Olivier Lascols, Vincent Laugel, Arnaud Lazarus, France Leturcq, Nicolas Lévy, Armelle Magot, Véronique Manel, Raphaël P. Martins, M. Mayer, Sandra Mercier, Christophe Meune, Maud Michaud, Marie-Christine Minot-Myhié, Antoine Muchir, Aleksandra Nadaj‐Pakleza, Yann Péréon, Philippe Petiot, Florence Petit, Julien Praline, Anne Rollin, Pascal Sabouraud, Catherine Sarret, S. Schaeffer, Frédéric Taithe, Céline Tard, V. Tiffreau and 10 more - Circulation 2019 cited by 260

  8. X‐chromosome inactivation in female patients with Fabry disease

    Authors: , , , , , , , , , - Clinical Genetics 2015 cited by 417

  9. Myocardial Stiffness Evaluation Using Noninvasive Shear Wave Imaging in Healthy and Hypertrophic Cardiomyopathic Adults

    Authors: , , , , , , , , , , , - JACC. Cardiovascular imaging 2018 cited by 182

  10. Exercise Capacity in Patients With Obstructive Hypertrophic Cardiomyopathy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - JACC Heart Failure 2023 cited by 46

  11. Long-term effect of mavacamten in obstructive hypertrophic cardiomyopathy

    Authors: , , , , , , , , , , , , , , , , , , - European Heart Journal 2024 cited by 94

  12. Mitral valve disease—morphology and mechanisms

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Russell A. Norris, David S. Peal, M. Perrocheau, Vincent Probst, Michael Pucéat, Nadia Rosenthal, Jorge Solı́s, Jean‐Jacques Schott, Ehud Schwammenthal, Susan A. Slaugenhaupt, Jae‐Kwan Song, Magdi H. Yacoub, for the Leducq Mitral Transatlantic Network - Nature Reviews Cardiology 2015 cited by 383

  13. Cardiovascular progenitor–derived extracellular vesicles recapitulate the beneficial effects of their parent cells in the treatment of chronic heart failure

    Authors: , , , , , , , , , , , , , , , , , , , - The Journal of Heart and Lung Transplantation 2016 cited by 198

  14. Acellular therapeutic approach for heart failure: in vitro production of extracellular vesicles from human cardiovascular progenitors

    Authors: , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2018 cited by 165

  15. Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report: Figure 1

    Authors: , , , , , , , , , , , , , , , , , - European Heart Journal 2015 cited by 434

  16. Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Songsak Kiatchoosakun, Kee‐Sik Kim, Ömer Kozan, Edmundo Bayram Llamas, Felipe Martínez, Béla Merkely, Iván Mendoza, Arend Mosterd, Marta Negrusz‐Kawecka, Keijo Peuhkurinen, Félix José Alvarez Ramires, Jens Refsgaard, Arvo Rosenthal, Michele Senni, Antonio S. Sibulo, José Silva‐Cardoso, Iain Squire, Randall C. Starling, John R. Teerlink, Johan Vanhaecke, Dragoş Vinereanu, Raymond Wong - Circulation 2014 cited by 667

  17. Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness

    Authors: , , , , , , , , , , , , , , , , , - European Heart Journal 2015 cited by 243

  18. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial

    Authors: , , , , , , , , , , , , , , - Circulation 2008 cited by 943

  19. Genome-wide association study reveals novel genetic loci: a new polygenic risk score for mitral valve prolapse

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert A. Levine, Emelia J. Benjamin, Ramachandran S. Vasan, Benjamin D. Horne, Joseph B. Muhlestein, Giovanni Benfari, Maurice Enriquez‐Sarano, Andrea Natale, Sanghamitra Mohanty, Chintan Trivedi, Moore B. Shoemaker, Zachary T. Yoneda, Quinn S. Wells, Michael Baker, Eric Farber‐Eger, Héctor I. Michelena, Alicia Lundby, Russell A. Norris, Susan Slaugenhaupt, Christian Dina, Steven A. Lubitz, Nabila Bouatia‐Naji, Patrick T. Ellinor, David J. Milan - European Heart Journal 2022 cited by 70

  20. Serial left ventricular adaptations in world-class professional cyclists

    Authors: , , , , , , - Journal of the American College of Cardiology 2004 cited by 253

  21. Effect of Losartan on Mitral Valve Changes After Myocardial Infarction

    Authors: , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2017 cited by 123

  22. Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Glikson, Alastair Gray, Meral Kayıkçıoğlu, Aldo P. Maggioni, Klaudia Vivien Nagy, Aleksandr Nedoshivin, Anna-Sonia Petronio, Jolien Roo Hesselink, Lars Wallentin, Uwe Zeymer, Alida Caforio, Juan R. Gimeno, Philippe Charron, Perry Elliott, Juan Pablo Kaski, Aldo P. Maggioni, Luigi Tavazzi, Michał Tendera, С. М. Комиссарова, Н. Н. Чакова, S. S. Niyazova, Aleš Linhart, Petr Kuchynka, T Palecek, Jana Podzimková, Marek Fikrle, Eneida R. Nemecek, Henning Bundgaard, Jacob Tfelt‐Hansen, Juliane Theilade, Jens Jakob Thune, Å.B. Axelsson, Jens Mogensen, F.L. Henriksen, Thomas Morris Hey, Søren K. Nielsen, Lars Videbæk, Simon Andreasen, H Arnsted, Anas M. Saad, Muzaffar Ali, Jyri Lommi, Tiina Heliö, M S Nieminen, Olivier Dubourg, Nicolas Mansencal, Murat Nihat Arslan, V. Siam Tsieu, Thibaud Damy, Aziz Guellich, Soulef Guendouz, Claire Marie Tissot, Aurélia Lamine, Stéphane Rappeneau, Albert Hagège, Michel Desnos, A Bachet, M. Hamzaoui, Philippe Charron, R Isnard, L. Legrand, Carole Maupain, Estelle Gandjbakhch, Mathieu Kernéis, J.F. Pruny, Anna Bauer, Barbara Pfeiffer, S B Felix, Marcus Dörr, S Kaczmarek and 277 more - European Heart Journal - Quality of Care and Clinical Outcomes 2022 cited by 44

  23. First-in-man use of a cardiovascular cell-derived secretome in heart failure. Case report

    Authors: , , , , , , , , , , , , , - EBioMedicine 2024 cited by 34

  24. Primary cilia defects causing mitral valve prolapse

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ronen Durst, Roger R. Markwald, Solena Le Scouarnec, Albert Hagège, Thierry Le Tourneau, Peter Köhl, Eva A. Rog‐Zielinska, Patrick T. Ellinor, Robert A. Levine, David J. Milan, Jean‐Jacques Schott, Nabila Bouatia‐Naji, Susan A. Slaugenhaupt, Russell A. Norris - Science Translational Medicine 2019 cited by 112